{
  "id": "BIOC406_Exam1A_Q10",
  "question": "Hartnup disease is a genetic syndrome in which there is an inactivating mutation in a gene required for the absorption of tryptophan. Based on this information, which of these drugs might help treat the neurological symptoms of patients with Hartnup disease?",
  "choices": {
    "A": "A selective serotonin reuptake inhibitor (SSRI).",
    "B": "A dopamine reuptake inhibitor.",
    "C": "An antihistamine.",
    "D": "Reserpine, which depletes monoamines from synaptic vesicles.",
    "E": "A GPCR inhibitor. Page 4 A Biochemistry 406 Jan. 26, 2026 Exam 1 - Version"
  },
  "answer": [
    "A"
  ],
  "answer_format": "letters",
  "source": {
    "exam_pdf": "data/406_exam 1_A.pdf",
    "key_pdf": "data/406_exam 1_A KEY_UPDATED.pdf",
    "question_number": 10
  }
}